Pollack, P. S., Chadwick, K. D., Smith, D. M., Billger, M., Hirshberg, B., Iqbal, N., & Boulton, D. W. (2017). Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin. Cardiovasc Diabetol.
Styl ChicagoPollack, Pia S., Kristina D. Chadwick, David M. Smith, Martin Billger, Boaz Hirshberg, Nayyar Iqbal, a David W. Boulton. "Nonclinical and Clinical Pharmacology Evidence for Cardiovascular Safety of Saxagliptin." Cardiovasc Diabetol 2017.
Citace podle MLAPollack, Pia S., et al. "Nonclinical and Clinical Pharmacology Evidence for Cardiovascular Safety of Saxagliptin." Cardiovasc Diabetol 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..